I feel a complete fraud writing about my most recent infusion visit because there just isn’t anything to write about! Having arrived in the department around 9am last Monday morning, I climbed onto the scales to be weighed and that, dear reader, was the ONLY thing I had to do, except for the beloved suicide questionnaire (still no successful attempts to report). I thought it might be a long morning, but actually once I’d had a bit of a doze, umpteen cups of coffee and chatted with the nurses as they came in and out, it was soon lunch time. It was a bright sunny day in London so after lunch I decided I would go and stand just outside the door and watch the world go by – quite an adventure for me, as I never voluntarily go outside, so Colin came with me and I found a nice spot to lean against the railings. It didn’t turn out to be one of my better ideas, as the walkway was very busy and I was a bit worried about getting walloped in the shins by the folks in wheelchairs going past me, so fairly shortly we headed back inside. Just inside the main door I heard footsteps close behind me and I froze, and braced myself against Colin. Sure enough, someone bumped into me with their huge canvas backpack and if I hadn’t been ready for it I would surely have gone down like a sack of spuds.
That crisis averted, we were greeted back in the department by the news that the drug had arrived, and I was hooked up to the drip in no time. We decided to use a vein in my left wrist that has proved to be very co-operative in the last few months, and my left arm lifted itself from my lap up onto the pillow on the arm of the infusion chair without any help from my right arm whatsoever. My nurse and I looked at it in amazement, and I did it again, just to check. The nurse trotted off to get the study doctor to witness my new ability – my left arm has been pretty much useless for years! This most dramatic event was entered into my notes, while I grinned and kept lifting my arm up, just in case it forgot how to do it. Once the excitement had subsided, the infusion was done and we were on our way by about 2.15pm. It was a horrible journey back from London in quite heavy rain, and it was still raining when we got home. Colin helped me out of the car and I broke all speed records walking up the drive to the front door – I suppose I was so intent on getting out of the rain I forgot to be scared of falling over. Anyway, I got up the steps and into the house with no problems and that was all done for another month.
So, onto this month’s facts and figures, and I must ask my friend Margaret Creech to please sit down now because I don’t want you getting giddy! Here goes:
Time taken to get dressed: 5 minutes 11 seconds, down from 5 minutes 55 seconds last month
Time taken to walk to kitchen and come back with coffee: 4 minutes 46 seconds, down from 5 minutes 19 seconds last month
This month’s mark on the door frame is higher again, just by an inch or so
And the foot lift measurements are: Right 4.75 inches (up from 4 inches) – Left 3.75 inches (up from 3.5 inches)
What does all this tell us? I don’t know really. For me personally it illustrates that my mobility is improving – whether or not that is because of extra strength, whether it is due to the effects of the drug, or exercise, or a combination of both, is unknown at this stage but the reasons don’t matter much to me at all. I’m doing better than I was a couple of months ago, and when you’ve got a progressive muscle disease that’s pretty amazing in itself.
As I prepared to post this entry, a Facebook friend posted a link to an article stating that this drug, BYM338, has failed to produce the results expected in trials with sIBM. At present there are no plans to discontinue the ongoing trials, and I guess all we can do is hope for the best. I have no medical knowledge whatsoever, but it seemed to me from the outset that the doses being used in this phase of the trial are far too low – 10mg, 3mg and 1mg per kg of patients body weight, compared with 30mg per kg body weight in the initial ‘proof of concept’ phase. Perhaps this made sense to somebody, but it never made any sense to me. There are no plans to cancel the ongoing clinical trials at present, but obviously the financial implications of this result for Novartis place a huge question mark over the whole thing. If I hear anything at all through the official channels I will post an update here.